Canadian Institutes of Health Research
570,556 snapshots · latest May 3, 2026
Homepage:https://cihr-irsc.gc.ca/
Archive explorer
Browse & search snapshots
Important note
Browse and search historical snapshots. This is an archive — not current guidance or medical advice. Archived content may be incomplete, outdated, or superseded. For up-to-date recommendations, always consult the official source website.
For background on coverage and capture methods, see Methods & coverage.
Browse archived sites
Health Canada
386,223 snapshots · latest Apr 14, 2026
Public Health Agency of Canada
243,880 snapshots · latest Apr 28, 2026
Donating and using third-party sperm or ova (eggs) for assisted human reproduction On this page Donor sperm and ova (eggs) Donor screening and testing Regulating third party sperm and ova (eggs) Compliance monitoring activities in Canada Donor sperm and ova (eggs) Donor sperm and…
Risk classification guide for the safety of sperm and ova observations (GUI-0129) Download the alternative format (PDF format, 1.09 MB / KB, 19 pages) Organization: Health Canada Published: 2020-02-04 Updated: 2020-02-04 Author: Regulatory Operations and Enforcement Branch Date…
Carrières En tant qu’organisme fédéral chargé d’investir dans la recherche en santé, les Instituts de recherche en santé du Canada (IRSC) soutiennent les travaux de milliers de chercheurs. Grâce à leurs investissements dans la recherche de premier ordre, les IRSC améliorent la…
Compliance approach for the Reimbursement Related to Assisted Human Reproduction Regulations Disclaimer This document does not constitute part of the Assisted Human Reproduction Act (AHR Act) or its regulations and in the event of any inconsistency or conflict between the AHR Act…
Inspection approach: Safety of Sperm and Ova Regulations (POL-0125) Download the alternative format (PDF format, 1.16 MB / KB, 13 pages) Organization: Health Canada Published: 2020-02-04 Updated: 2020-02-04 Author: Regulatory Operations and Enforcement Branch Date issued:…
Summary - Use of Positron-emitting Radiopharmaceuticals in Basic Clinical Research Overview The purpose of this guidance document is to provide information to sponsors who use positron-emitting radiopharmaceuticals in basic clinical research studies and to assist them in…
Health Canada Policy Position Paper – Autologous Cell Therapy Products Purpose Many emerging autologous Footnote 1 cell therapy products may eventually prove to be safe and effective. However, most of these products are currently at the investigational stage of development with…
Health Canada Notice regarding products that contain human placenta In recent years there has been an increasing public interest in placentophagy, which is the consumption of the placenta following the birth of a child. Placenta has been known to be consumed raw, dehydrated or…
Health Canada’s 2017 Biosimilars Workshop: Summary Report On March 20, 2017, Health Canada hosted a workshop on biosimilars. The objectives of the workshop were to educate stakeholders on the federal regulatory approach to biosimilars following release of the updated Guidance…
Guidance Document: Interim Compliance Approach Regarding the Testing of Semen Donors for Treponema pallidum (Syphilis) We have archived this page and will not be updating it. You can use it for research or reference. We have archived this page and will not be updating it. You can…
Early release: coverage and features are still expanding.
